Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2003
Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cellsSei-Ichi Yusa, Kerry S CampbellJournal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cellsSei-ichi Yusa, Tracey L Catina, Kerry S CampbellJournal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2)Sei-ichi Yusa, Tracey L Catina, Kerry S CampbellJournal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma productionAkiko Kikuchi-Maki, Sei-ichi Yusa, Tracey L Catina, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequenceKerry S Campbell, Sei-ichi Yusa, Akiko Kikuchi-Maki, et al.Viruses|December 4, 2012
Cellular prion protein: from physiology to pathologySei-ichi Yusa, José B Oliveira-Martins, Yoshiko Sugita-Konishi, et al.Plos One|February 18, 2010
Unexpected tolerance of alpha-cleavage of the prion protein to sequence variationsJosé B Oliveira-Martins, Sei-ichi Yusa, Anna Maria Calella, et al.Scientific Reports|February 23, 2012
Cross priming amplification: mechanism and optimization for isothermal DNA amplificationGaolian Xu, Lin Hu, Huayan Zhong, et al.Veterinary Immunology and Immunopathology|May 26, 2009
Evaluation of immunological status in tumor-bearing dogsHiroshi Itoh, Yutaka Horiuchi, Teppei Nagasaki, et al.Anticancer Research|November 5, 2014
Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapyShigeo Koido, Shin Kan, Kosaku Yoshida, et al.Pageof 2